Company intelligence / Profile preview
TCRCure Biotech
Los Angeles, California, USAen.tcrcure.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Phase 1
01
Overview
TCRCure has demonstrated early clinical activity with its engineered cell therapies. Notably, its LMP2-specific IL12-secreting TCR-T therapy has reached Phase I/II in nasopharyngeal cancer. The company was the first to apply anti-PD1 augmented TCR-T cells in advanced recurrent solid tumors. Several other programs are ongoing or paused at early-stage clinical development.
- Therapeutic areas
- Oncology
- Modalities
- Engineered T-cell therapies (TCR-T, CAR-T)Autologous CAR-T cellsSynthetic peptide therapies
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with major hospitals worldwide for translational research and clinical trialsAcademic collaboration with Duke UniversityPartnership/sponsorship noted with Hervor Therapeutics
Beyond the preview
Go deeper on TCRCure Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TCRCure Biotech.